Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
Hematological Oncology · 2024
DOI: 10.1002/hon.3248 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hematological Oncology, 2024. Verfasst von Taku Kikuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
ORCID-Profile: Taku Kikuchi
Zitieren
APA
Kikuchi, T., Tsukada, N., Kunisada, K., Yogo, M., Oda, Y., Sato, K., Takei, T., Ogura, M., Abe, Y., Suzuki, K., & Ishida, T. (2024). Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Hematological Oncology. https://doi.org/10.1002/hon.3248
Vancouver
Kikuchi T, Tsukada N, Kunisada K, Yogo M, Oda Y, Sato K, et al. Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Hematological Oncology. 2024. doi:10.1002/hon.3248
BibTeX
@article{Kikuchi2024,
author = {Kikuchi, Taku and Tsukada, Nobuhiro and Kunisada, Kodai and Yogo, Moe and Oda, Yuki and Sato, Kota and Takei, Tomomi and Ogura, Mizuki and Abe, Yu and Suzuki, Kenshi and Ishida, Tadao},
title = {Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3248}
}
EUVIMED